Robert B. Huizinga

29 papers receiving 749 citations

Robert B. Huizinga's Hit Papers

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial 2021 · 335 citations
3350+1+3Years since publication100200300

Peers

Robert B. Huizinga
Comparison fields: 5 of 53
  • Transplantation 106
  • Rheumatology 460
  • Nephrology 154
  • Hepatology 82
  • Immunology 204
Replace Sandra Navarra with:
Sandra Navarra Philippines
Claudio Ponticelli Italy
Johnny Sayegh France
Louise Oni United Kingdom
Yohan Duny France
Ana Huerta Spain
Carlos Chiurchiu Argentina
Harish Seethapathy United States
S. Mulgaonkar United States
Giuseppe Picciotto Italy
Robert B. Huizinga relative to Sandra Navarra Philippines Sandra Navarra's profile →
Citations per field
00.5×9.6×
Sandra Navarra · 1×
Citations per year

Countries citing papers authored by Robert B. Huizinga

Since Specialization
Citations

This map shows the geographic impact of Robert B. Huizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Huizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Huizinga more than expected).

Fields of papers citing papers by Robert B. Huizinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Huizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Huizinga. The network helps show where Robert B. Huizinga may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert B. Huizinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert B. Huizinga Line = papers co-authored together Robert B. Huizinga links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Hit paper breakdown →
2021335
2 201168
3 200867
4 202358
5 200645
6 202241
7 202227
8 202023
9 202121
10 201318
11 201313
12 200812
13 201312
14 201311
15 20208
16 20177
17 20205
18 20204
19 20173
20 20252

About Robert B. Huizinga

Robert B. Huizinga is a scholar working on Rheumatology, Transplantation, Hepatology, Molecular Biology and Nephrology, having authored 36 papers that have together received 793 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (13 papers), Systemic Lupus Erythematosus Research (13 papers), Hepatitis C virus research (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Blood groups and transfusion (3 papers), HIV/AIDS drug development and treatment (3 papers), Liver Diseases and Immunity (3 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Transplantation (106 citations), Rheumatology (460 citations), Nephrology (154 citations), Hepatology (82 citations) and Immunology (204 citations). Robert B. Huizinga has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Laura Lisk, Neil Solomons, Samir V. Parikh, Simrat Randhawa, Dawn J. Caster, Keisha L. Gibson, Cristina Arriens, Y K Onno Teng, Ellen M. Ginzler and Brad H. Rovin. Their work appears in journals such as Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation, The Journal of Clinical Pharmacology, The Lancet and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact